Advertisement
- United States
- /
- Biotech
- /
- NasdaqGS:TWST
Twist Bioscience Second Quarter 2025 Earnings: EPS Misses Expectations
Twist Bioscience (NASDAQ:TWST) Second Quarter 2025 Results
Key Financial Results
- Revenue: US$92.8m (up 23% from 2Q 2024).
- Net loss: US$39.3m (loss narrowed by 14% from 2Q 2024).
- US$0.66 loss per share (improved from US$0.79 loss in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Twist Bioscience EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 22%.
Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Biotechs industry in the US.
Performance of the American Biotechs industry.
The company's shares are down 21% from a week ago.
Risk Analysis
You should learn about the 2 warning signs we've spotted with Twist Bioscience.
Valuation is complex, but we're here to simplify it.
Discover if Twist Bioscience might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:TWST
Excellent balance sheet and slightly overvalued.
Market Insights
Advertisement
Weekly Picks
WE
WealthAP on PayPal Holdings ·
The "Sleeping Giant" Stumbles, Then Wakes Up
Fair Value:US$8229.7% undervalued
71 followersusers have followed this narrative
5 commentsusers have commented on this narrative
34 likesusers have liked this narrative
WO
woodworthfund on Bumble ·
Swiped Left by Wall Street: The BMBL Rebound Trade
Fair Value:US$960.1% undervalued
22 followersusers have followed this narrative
0 commentsusers have commented on this narrative
6 likesusers have liked this narrative
WE
WealthAP on Duolingo ·
Duolingo (DUOL): Why A 20% Drop Might Be The Entry Point We've Been Waiting For
Fair Value:US$268.6441.8% undervalued
43 followersusers have followed this narrative
5 commentsusers have commented on this narrative
9 likesusers have liked this narrative
Recently Updated Narratives
LE
LeStockPicker on Novo Nordisk ·
Probably the best stock I've seen all year.
Fair Value:DKK 90058.0% undervalued
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
DE
Deep_Insights on Hims & Hers Health ·
Hims & Hers Health aims for three dimensional revenue expansion
Fair Value:US$173.0281.9% undervalued
8 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
RO
RockeTeller on Thor Explorations ·
West Africa's 20 Baggers Gold Play (Nigeria/Senegal)
Fair Value:CA$3295.6% undervalued
3 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Popular Narratives
WE
WealthAP on PayPal Holdings ·
The "Sleeping Giant" Stumbles, Then Wakes Up
Fair Value:US$8229.7% undervalued
71 followersusers have followed this narrative
5 commentsusers have commented on this narrative
34 likesusers have liked this narrative
AL
AlexLovell on Rocket Lab ·
Early mover in a fast growing industry. Likely to experience share price volatility as they scale
Fair Value:US$16.25464.9% overvalued
75 followersusers have followed this narrative
1 commentusers have commented on this narrative
18 likesusers have liked this narrative
AG
Agricola on Excellon Resources ·
A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).
Fair Value:CA$31.898.3% undervalued
72 followersusers have followed this narrative
15 commentsusers have commented on this narrative
23 likesusers have liked this narrative
Trending Discussion
WA
Wane_Investment_House on Airtel Africa ·
Airtel Africa Plc – Recalibrated Valuation Highlights Compelling Relative Value Equity analysts highlight that Airtel’s stock remains undervalued relative to regional peers, presenting an attractive entry point for investors seeking exposure to a resilient, data-driven telecom business. Strategic Insights • Revenue Mix Transformation: The transition from voice to data highlights Airtel’s alignment with global telecom trends and positions the company to capture higher-margin opportunities in mobile data and digital services. • Operational Levers: Subscriber growth, tariff adjustments, and disciplined cost management provide a solid foundation for near-term growth. • Valuation Drivers: Adjustments to the equity risk premium (13.8% vs. 14.3%) and lower yields on Nigeria’s 10-year Eurobond (7.7% vs. 10.4%) have slightly tempered valuation, but the fundamentals remain strong. Analyst Commentary • Near-term Upside: The revised target price suggests significant potential gains, particularly given Airtel’s operational resilience and structural growth in data usage. • Investment Considerations: Investors seeking exposure to defensive growth in telecom should view Airtel as a long-term opportunity, with upside supported by undervaluation relative to regional peers. • Risk Factors: Currency appreciation (Naira strength), potential regulatory changes, and macroeconomic volatility remain key considerations for risk-adjusted returns. Conclusion Airtel Africa Plc combines robust operational performance, a favorable shift to data revenue, and strategic macro positioning with an undervalued stock price relative to peers. Despite muted market response in 2025, the recalibrated target price and potential upside of 72% underscore Airtel’s attractiveness for long-term investors seeking resilient, growth-oriented exposure in the African telecom sector.
0
|0
